Medication recall

Lupron Can Result in Serious Injury or Death

Lupron is a hormonal regulator that has several dangerous, if not oft-publicized side effects of which every patient should be aware. The drug is prescribed to help slow early-onset puberty in teenagers, to men who exhibit signs of prostate cancer, and to help treat women with endometriosis, a rare condition in which the lining of the uterus grows outside the actual uterus. According to the U.S.
Continue Reading »

The Return of Fen-Phen Pills

The product first hailed as a miracle weight-loss drug and subsequently pulled from the market when its dangers became apparent has resurfaced, albeit in another format. But the new drug has some of the same health concerns, and some new ones as well. Fen-Phen
Continue Reading »

Supreme Court Ruling Makes It Difficult To Sue Manufacturers

Last year, a Supreme Court ruling came down that will affect thousands of Americans, even if they were not aware of the ruling. Building on a ruling that declared manufacturers of medical devices could, in some cases, enjoy immunity status if the device turned out to be defective, last year’s case determined that no patient could challenge a manufacturer in state court if it had been approved at the federal level.
Continue Reading »

FDA Issues Largest-Ever Medical Product Recall in 2014

The U.S. Food and Drug Administration (FDA) issued its largest recall of medical products ever in 2014, according to the Regulatory Affairs Professional Society (RAPS). The recall, posted to the FDA’s website in August, was of 233 Class I products manufactured by Puerto Rico-based Customed.
Continue Reading »

Mental Disorder Drug Linked to Risk of Compulsive Behavior

Abilify is the name brand of the medication aripirazole. Aripirazole is the medicine used to treat mental disorders such as bipolar disorder, severe mental depression and schizophrenia. No evidence has been released that proves that the drug does not do what it is intended to do, but there are some unexpected side effects of taking this medication about which many patients have filed lawsuits.
Continue Reading »

Antidepressant Paxil Linked to Birth Defects

When the antidepressant drug Paxil hit the consumer market in the early 1990s, it was hailed by the medical world as a wonder drug, able to relieve even the most severe cases of mental depression. Like most other antidepressants, Paxil is a selective serotonin reuptake inhibitor (SSRI). There have been widely-publicized side effects about SSRIs for the patient who takes them. However, not as much has been published about the effects SSRIs can have on babies born to women who are taking them.
Continue Reading »

Another Compound Pharmacy Recall Due to Contamination Issues

The U.S. Food and Drug Administration (FDA) recently issued a warning to physicians across the country not to use any compounded drugs that were manufactured by Unique Pharmaceuticals because of possible contamination. This action was done in response to an FDA inspection of the company’s Temple, Texas manufacturing plant, where inspectors found issues with medication production that may have compromised the sterility of the medication.
Continue Reading »

Generic Drugs and Defective Drug Claims

A generic drug is an essential option for Americans, as it is sold at a lower cost than a name brand product. In fact, the FDA notes that generic brands can be as much as 85 percent lower in price. However, these lower prices are a direct result of several factors. One of these factors is that generic drug manufacturers are not required to “repeat the costly clinical trials of new drugs.”
Continue Reading »

FDA Requires Makers of Testosterone Therapy to Include Warnings

 In June, the Food and Drug Administration (FDA) issued a statement requiring drug-makers who manufacture testosterone to issue a warning label on the drug regarding the potential risk for venous blood clots. Testosterone replacement drugs are a medicinal therapy for men with erectile dysfunction, though according to WebMD, “inadequate production of testosterone is not a common cause of ED.”
Continue Reading »

FDA to Increase Access to Drug and Product Recall Information

The Food and Drug Administration (FDA) recently announced that it is conducting a pilot program to expedite drug recall notifications in an effort to quickly and efficiently relay important information to the public. The Agency, according to the FDA, currently issues a weekly Enforcement Report for consumers to be informed about the risks posed by products on the market.
Continue Reading »

Pages

  • Newland & Newland LLP, Attorneys, Arlington Heights, IL
  • Lawyer.com